Treatment Approaches in Advanced Urothelial Cancer

Insight regarding the utilization of antibody-drug conjugate therapy to treat relapsed/refractory advanced bladder cancer.

EP. 1: Advanced Bladder Cancer: Adopting Newer Therapies into Clinical Practice

February 3rd 2022

Bradley McGregor, MD, reacts to treatment advances for advanced bladder cancer and shares perspective on utilizing newer, novel therapies as the field continues to evolve

EP. 2: Encouraging Developments in Therapies for Relapsed/Refractory Advanced Bladder Cancer

February 7th 2022

Dr Benjamin Miron highlights data specific to treating patients with relapsed metastatic disease.

EP. 3: Treating R/R Advanced Bladder Cancer With Novel Sequencing Strategies

February 7th 2022

UCSF Health’s Vadim S. Koshkin, MD, highlights approaches for sequencing novel therapies into treatment algorithms for patients with relapsed/refractory advanced bladder cancer.

EP. 4: Study EV-103 in Advanced Bladder Cancer

February 7th 2022

Ali R. Khaki, MD, describes the impact of the EV-103 study of enfortumab vedotin in advanced bladder cancer.

EP. 5: Optimizing Therapy for Patients with Advanced Bladder Cancer

February 7th 2022

Ali R. Khaki, MD, comments on how to treat patients with advanced bladder cancer based on data demonstrated by the EV-103 study of enfortumab vedotin.